Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors

BACKGROUND: Cancer survival rates have been steadily improving in the adolescent and young adult (AYA) population, but survivors are at increased risk for cardiovascular disease (CVD). The cardiotoxic effects of anthracycline therapy have been well studied. However, the cardiovascular toxicity assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong-Siegel, Jeannette R., Hayashi, Robert J., Foraker, Randi, Mitchell, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327375/
https://www.ncbi.nlm.nih.gov/pubmed/37420285
http://dx.doi.org/10.1186/s40959-023-00181-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327375/
https://www.ncbi.nlm.nih.gov/pubmed/37420285
http://dx.doi.org/10.1186/s40959-023-00181-2

Ejemplares similares